Clinical Trial Update: AVL200 IOL for Treatment of Cataract and Presbyopia [NA]

View source ↗

Summary

Update on a completed clinical trial evaluating AVL200 intraocular lens (IOL) for cataract and presbyopia, sponsored by Atia Vision.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Presbyopia

Drugs mentioned

• AVL200 intraocular lens (AVL200 intraocular lens)

Snippet

Sponsor: Atia Vision | Conditions: Cataract | NA | Status: COMPLETED